<html lang="en">

<head>
    <title>Pediatric Hypoglycemia</title>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width,initial-scale=1.0" />
    <link rel="stylesheet" href="cpgPedEr.css" />

</head>

<body>
    <div id="header-container"></div>
    <header class="page-header">Pediatric Hypoglycemia</header>

    <div class="container">
        <p class="cpg-headers">DEFINITION</p>
        <ul>
            <li>Normal plasma glucose 70 to 100 mg/dL</li>
            <li> Diagnostic threshold- Hypoglycemia is &lt;50 mg/dL</li>
            <li>Treatment goal maintain a plasma glucose >70 mg/dL</li>
        </ul>
        <div class="border-btm"></div>
        <p class="cpg-headers">SYMPTOMS OF HYPOGLYCEMIA</p>

        <ul>
            <li>Neurogenic (Sympathetic)</li>
            <ul>
                <li>Appears if plasma glucose is less than 55- 60 mg/dL.</li>
                <li>Sweating, tremor, palpitations, tachycardia, and hunger.</li>
                <li>repeat exposure to hypoglycemia can blunt or eliminate them</li>
            </ul>
            <li>Neuroglycopenic (insufficient supply of glucose to the brain)</li>
            <ul>
                <li>Occurs when the plasma glucose falls below 50 mg/dL.</li>
                <li>Lethargy, confusion, irritability, loss of consciousness, and seizure.</li>
            </ul>
        </ul>

        <div class="border-btm"></div>
        <p class="cpg-sub-headers">Blood glucose needs to be measured for infant and children with:</p>
        <ul>
            <li>Acute illness (e.g., sepsis, shock, burns)</li>
            <li>Altered Glasgow Coma Scale, loss of consciousness</li>
            <li>Seizure</li>
            <li>Vomiting</li>
            <li>Lethargy</li>
            <li>Reduced oral intake</li>
            <li>Liver disease</li>
            <li>Accidental ingestion of drugs especially</li>
            <ul>
                <li>Salicylates</li>
                <li>Hypoglycemic agents</li>
                <li>Beta-blockers</li>
                <li>Quinine</li>
            </ul>
        </ul>

        <div class="border-btm"></div>
        <p class="cpg-headers">INDICATIONS FOR EVALUATION</p>
        <ul>
            <li>For infants and younger children who are unable to reliably communicate symptoms, evaluate those whose
                plasma glucose concentrations are &lt; 60 mg/dL, as documented by a laboratory-quality assay (a
                point-of-care test is not sufficient).</li>
            <li> For children who are able to communicate their symptoms, evaluate those who demonstrate Whipple triad
                (symptoms consistent with hypoglycemia, low plasma glucose concentration, and resolution of symptoms
                with normalization of plasma glucose)</li>
        </ul>

        <div class="border-btm"></div>
        <p class="cpg-headers">TREATMENT</p>
        <p class="cpg-sub-headers">GLUCOSE THERAPY</p>
        <ul>
            <li><strong>Conscious cooperative child</strong></li>
            <ul>
                <li>15 g (or 0.2 g/kg for infants) of rapid-acting carbohydrate should be given by mouth (can be from
                    dextrose solutions)</li>
                <li>Can be supplied by 125 ml juice or biscuits</li>
                <li>IV access recommended since child's glucose may not to respond to oral intervention.</li>
            </ul>
            <li><strong>Patient with altered consciousness</strong></li>
            <ul>
                <li>IV Dextrose</li>
                <li>Initial bolus 2 mL/kg of dextrose 10%</li>
                <li>If glucose fails to increase after 15-20 minutes, repeat the bolus</li>
                <li>Higher concentrations of dextrose are not recommended</li>
            </ul>
            <li><strong>Dextrose infusion</strong></li>
            <ul>
                <li>After the initial bolus, a dextrose infusion should be started to prevent recurrent hypoglycemia.
                </li>
                <li>Infants should be started on a glucose infusion rate (GIR) of 5-6 mg/kg/minute (Dextrose 10%)</li>
                <li>Older children 2-3 mg/kg/minute (dextrose 5%)</li>
                <li>GIR should be increased by 0.5-1 mg/kg/minute if the patient continues to have plasma glucoses
                    &lt;70 mg/dL.</li>
                <li>GIR = (dextrose percentage rate of infusion [mL/hr]) (6 weight [kg])</li>
            </ul>
            <li><strong>Glucagon</strong></li>
            <ul>
                <li>If the child's mental status is altered and intravenous access cannot be obtained,</li>
                <li>1 mg intramuscularly (regardless of body weight).</li>
                <li>Glucagon is only effective for patients with suspected insulin-mediated hypoglycemia
                    (hyperinsulinism, insulin administration, or sulfonylurea ingestion Glucagon is not effective in
                    other forms of hypoglycemia)</li>
            </ul>
        </ul>
        <div class="border-btm"></div>
        <p class="cpg-headers">MONITORING</p>
        <ul>
            <li>Every 15-20 minutes until it is >70 mg/dL</li>
            <li>Thereafter, it can be checked hourly to ensure stability, and then subsequent checks can be further
                spaced to every three to four hours.</li>
        </ul>
        <div class="border-btm"></div>
        <p class="cpg-headers">EVALUATION FOR THE CAUSE OF HYPOGLYCEMIA</p>

        <ul>
            <li><strong>History</strong></li>
            <ul>
                <li>Duration of fasting</li>
                <li>Concurrent illness</li>
                <li>Prior events</li>
                <li>Family history</li>
            </ul>
            <li><strong>Physical examination</strong></li>
            <ul>
                <li>Growth and development</li>
                <li>Dysmorphic features</li>
                <li>Hyperventilation</li>
                <li>Hepatomegaly (glycogen storage disease or defect in gluconeogenesis)</li>
                <li>Evidence of hypopituitarism (eg, micropenis or cleft lip or palate, short stature)</li>
                <li>Adrenal insufficiency (eg, recurrent abdominal pain, hyperpigmentation, anorexia, weight loss),</li>
                <li>Beckwith-Wiedemann syndrome (eg, omphalocele, hemihypertrophy, macroglossia, ear lobe crease).</li>
            </ul>
            <li><strong>Age at presentation</strong></li>
            <ul>
                <li>Neonatal period and early infancy Hyperinsulinism, disorders of gluconeogenesis, most inborn errors
                    of metabolism and panhypopituitarism</li>
                <li>First two years of life Glycogen storage disorders, growth hormone or cortisol deficiencies</li>
                <li>Toddlers and young children Ingestion, ketotic hypoglycemia, glycogen storage disorders</li>
                <li>School-aged children and adolescents Insulinoma, factitious hypoglycemia, other ingestions</li>
            </ul>
        </ul>

        <div class="border-btm"></div>
        <p class="cpg-headers">IDIOPATHIC KETOTIC HYPOGLYCEMIA</p>
        <ul>
            <li>The most common form of childhood hypoglycemia</li>
            <li>Presents at ages 18 mo to 5 yr and remits spontaneously by 8-9 yr</li>
            <li>Typically occur during illness and when food intake is limited</li>
            <li>Classic history (poor eating, difficult to arouse from sleep)</li>
            <li>Can be complicated by seizure</li>
            <li>Laboratory findings: hypoglycemia, ketonuria ; low plasma insulin ≤5 μU/mL, low plasma alanine</li>
        </ul>
        <div class="border-btm"></div>
        <p class="cpg-headers">CRITICAL SAMPLES</p>
        <p class="cpg-text">Obtain "critical sample" of blood and urine at the time of hypoglycemia (plasma glucose
            &lt;50 mg/dL)</p>
        <p class="cpg-text">Blood The critical blood sample should be tested for:</p>

        <ul>
            <li>Plasma glucose</li>
            <li>Beta-hydroxybutyrate (BOHB)</li>
            <li>Comprehensive metabolic panel</li>
            <li>Insulin</li>
            <li>C-peptide</li>
            <li>Free fatty acids (FFAs)</li>
            <li>Lactate</li>
            <li>Ammonia</li>
            <li>Cortisol</li>
            <li>Growth hormone</li>
            <li>Acyl-carnitine profile</li>
            <li>Free and total carnitines</li>
            <li>Urea, electrolytes</li>
            <li>Plasma amino acids</li>
            <li>Liver function test</li>
            <li>Thyroid function test</li>
            <li>17-hydroxyprogesterone(if infant with hyponatremia)</li>
            <li>Adrenocorticorticotrophic hormone(ACTH)</li>
        </ul>
        <p class="cpg-text">Urine organic acids, ketones and reducing substances.</p>
        <div class="border-btm"></div>
        <p class="cpg-headers">REFERRALS</p>
        <p class="cpg-text">Patients need to be referred for pediatric subspecialty evaluation and management if</p>
        <ul>
            <li>Persistent hypoglycemia</li>
            <li>Recurrent Hypoglycemia</li>
            <li>Fasting test is needed</li>
            <li>History, examination or laboratory results suggestive of chronic disease (genetic or endocrinology)</li>
        </ul>
    </div>
    <script src="/PedRef/js/header.js"></script>
</body>

</html>
